Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study.

Source:http://linkedlifedata.com/resource/pubmed/id/20390343

Download in:

View as

General Info

PMID
20390343